TEX21 Inhibitors
TEX21 inhibitors encompass a diverse array of chemical compounds that, through their unique mechanisms, converge on the common outcome of attenuating the activity of TEX21. Wortmannin and LY294002, both phosphoinositide 3-kinase (PI3K) inhibitors, achieve this by down-regulating the PI3K/Akt pathway, a crucial signal transduction route that, when inhibited, results in reduced phosphorylation of downstream proteins, including TEX21. Rapamycin, targeting the mTOR pathway, impedes protein synthesis regulation, which is vital for TEX21 function, thereby hindering the protein's activity. Concurrently, JNK pathway inhibition by SP600125 and p38 MAP kinase blockade by SB203580 could diminish TEX21 activity, assuming its regulation is associated with stress or cytokine responses. Furthermore, the MEK1/2 inhibitors U0126 and PD98059 impede ERK signaling, which could decrease transcriptional activation of TEX21 if it falls within their influence.
Moreover, MG132's role as a proteasome inhibitor may indirectly influence TEX21 activity by altering proteinstability and degradation, particularly if TEX21 is prone to such post-translational modifications. Dasatinib and PP2, both inhibitors of Src family kinases, and Go6983, a PKC inhibitor, can down-regulate signaling pathways that might be critical for TEX21's activation or function, leading to its decreased activity. On another front, Y-27632, by inhibiting ROCK kinases, could impact TEX21 activity indirectly through altering actin cytoskeleton dynamics, which is often linked to cellular signaling processes. Each of these inhibitors operates through distinct biochemical pathways, yet all contribute to the common goal of diminishing the functional activity of TEX21 by targeting specific molecular processes that are either directly or indirectly involved in its regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K). Inhibition of PI3K can down-regulate the PI3K/Akt signaling pathway, leading to a decrease in the phosphorylation and activity of various downstream proteins including TEX21. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is another specific inhibitor of PI3K. By blocking PI3K activity, LY294002 suppresses the PI3K/Akt pathway, which can result in reduced activation of downstream proteins, thereby decreasing the functional activity of TEX21. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin is an mTOR inhibitor that disrupts the mTORC1 signaling complex. Given that TEX21 function may be regulated by mTOR signaling through protein synthesis control, rapamycin can lead to a functional inhibition of TEX21 by impeding this pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). The JNK pathway can influence various cellular processes, and by inhibiting JNK, SP600125 may reduce the activity of proteins regulated by this pathway, such as TEX21. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase. By inhibiting p38 MAPK, it can affect the cellular response to stress and cytokines, potentially leading to a decrease in TEX21 activity if it is downstream of this pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which are upstream of the ERK pathway. Inhibition of MEK/ERK signaling can lead to reduced transcriptional activation of proteins regulated by this pathway, which may include TEX21. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132 is a proteasome inhibitor that can lead to the accumulation of polyubiquitinated proteins, potentially affecting the stability and degradation of proteins such as TEX21 if it is subject to proteasomal degradation. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Dasatinib is a Src family kinase inhibitor. Src kinases are involved in multiple signaling pathways, and their inhibition can lead to decreased activation of downstream proteins, potentially including TEX21 if it is part of those pathways. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $103.00 $293.00 $465.00 | 15 | |
Go6983 is a protein kinase C (PKC) inhibitor. PKC is involved in the regulation of various cellular functions, and inhibition of PKC may lead to reduced activity of proteins like TEX21, which could be regulated by PKC-mediated signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is a MEK inhibitor, specifically blocking the activation of MEK1/2. This leads to a downstream inhibition of ERK1/2, potentially decreasing the activity of proteins such as TEX21 if their function is influenced by the MEK/ERK pathway. | ||||||